Skip to main content
. Author manuscript; available in PMC: 2019 Feb 27.
Published in final edited form as: Eur J Heart Fail. 2018 Jun 3;20(10):1392–1400. doi: 10.1002/ejhf.1216

Table 4. Univariable and multivariable analyses for the primary and secondary end-points.

HR for Women vs Men All-Cause Mortality Cardiovascular Death Non-Sudden Death Sudden death
HR (95% CI) P HR (95% CI) P HR (95% CI) P HR (95% CI) P
Univariable 0.64 (0.44, 0.94) 0.020 0.58 (0.36, 0.93) 0.025 0.68 (0.44, 1.05) 0.088 0.58 (0.28, 1.21) 0.15
Multivariable* 0.61 (0.41, 0.92) 0.018 0.60 (0.35, 1.05) 0.074 0.63 (0.39, 1.02) 0.060 0.70 (0.30, 1.63) 0.41
HR based on Age
(per 10 years increase)
All-Cause Mortality Cardiovascular Death Non-Sudden Death Sudden death
HR (95% CI) P HR (95% CI) P HR (95% CI) P HR (95% CI) P
Univariable 1.32 (1.17, 1.48) <0.00001 1.12 (0.95, 1.31) 0.18 1.51 (1.29, 1.78) <0.00001 0.92 (0.73, 1.15) 0.47
Multivariable 1.36 (1.20, 1.55) <0.0001 1.16 (0.98, 1.37) 0.078 1.51 (1.26, 1.82) <0.00001 0.99 (0.78, 1.24) 0.90
*

adjusted for left ventricular ejection fraction, New York Heart Association Class, atrial fibrillation, left bundle branch block, smoking, the presence of late gadolinium enhancement, age and the presence of an implantable cardioverter defibrillator or cardiac resynchronisation therapy as time varying co-variates

adjusted for left ventricular ejection fraction, New York Heart Association Class, atrial fibrillation, left bundle branch block, smoking, the presence of late gadolinium enhancement, sex and the presence of an implantable cardioverter defibrillator or cardiac resynchronisation therapy as time varying co-variates